Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Shares Issued (2018 - 2025)

Cue Biopharma's Shares Issued history spans 6 years, with the latest figure at -$10.8 million for Q4 2024.

  • For Q4 2024, Shares Issued changed N/A year-over-year to -$10.8 million; the TTM value through Sep 2024 reached $10.8 million, up 2187.74%, while the annual FY2023 figure was $473000.0, N/A changed from the prior year.
  • Shares Issued for Q4 2024 was -$10.8 million at Cue Biopharma, down from $10.8 million in the prior quarter.
  • Across five years, Shares Issued topped out at $54.9 million in Q4 2020 and bottomed at -$10.8 million in Q4 2024.
  • The 4-year median for Shares Issued is $628391.0 (2020), against an average of $5.0 million.
  • The largest YoY upside for Shares Issued was 2452.78% in 2021 against a maximum downside of 99.02% in 2021.
  • A 4-year view of Shares Issued shows it stood at $54.9 million in 2020, then tumbled by 99.02% to $537782.0 in 2021, then crashed by 84.19% to $85000.0 in 2023, then tumbled by 12830.59% to -$10.8 million in 2024.
  • Per Business Quant, the three most recent readings for CUE's Shares Issued are -$10.8 million (Q4 2024), $10.8 million (Q3 2024), and $85000.0 (Q2 2023).